Basic principles and clinical advancements of muscle electrotransfer

Current Gene Therapy

Volumn 10, Issue 2, 2010, Pages 128-138

  Hojman, Pernille ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Clinical trials; Electric pulses; Electroporation; Electrotransfer; Gene therapy; Ion exchange; Muscle function; Skeletal muscle; Systemic secretion

Indexed keywords

PLASMID DNA;

CLINICAL TRIAL; DNA IMMUNIZATION; DNA TRANSFER; DRUG DELIVERY SYSTEM; ELECTROPORATION; GENE EXPRESSION; GENE TRANSFER; HUMAN; NONHUMAN; REVIEW;

ANIMALS; CLINICAL TRIALS AS TOPIC; DNA; ELECTROPORATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MUSCLE, SKELETAL; PLASMIDS; VACCINES, DNA;

EID: 77950957345     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310791110994     Document Type: Review

References (90)

1. Gene Therapy Clinical Trials Worldwide. http: //www.wiley.co.uk/ wileychi/genmed/clinical/ 2009. (GENERIC)
2. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J, Jr, Mir LM. Electrochemotherapy, a new antitumour treatment. First clinical phase I-II trial. Cancer 1993; 72(12): 3694-3700.
3. Daud AI, DeConti RC, Andrews S, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26(36): 5896-5903.
4. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1(7): 841-845.
5. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
6. Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D. Long term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci Paris 1998; 321: 893-899.
7. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16: 168-171.
8. Suzuki T, Shin B, Fujikura K, Matsuaki T, Takata K. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 1998; 425: 436-440.
9. Mir LM, Moller PH, Andre F, Gehl J. Advances in Genetics. 54 ed. Electric pulse-mediated gene delivery to various animal tissues. 2005; pp. 83-114.
10. Favard C, Dean DS, Rols MP. Electrotransfer as a non viral method of gene delivery. Curr Gene Ther 2007; 7(1): 67-77. (Pubitemid 46322289)
11. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96(8): 4262-4267. (Pubitemid 29190324)
12. Mathiesen I. Electropermeabilisation of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6: 508-514. (Pubitemid 29192659)
13. Muramatsu T, Arakawa S, Fukazawa K, et al. In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int J Mol Med 2001; 7(1): 37-42.
14. Frantescu A, Kakorin S, Toensing K, Neumann E. Adsorption of DNA and electric fields decrease the rigidity of lipid vesicle membranes. Phys Chem 2005; 7(24): 4126-4131.
15. Golzio M, Teissie J, Rols MP. Direct visualisation at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci USA 2002; 99(3): 1292-1297. (Pubitemid 34136486)
16. Neumann E, Kakorin S, Toensing K. Fundamentals of electroporative delivery of drugs and gene. Bioelectrochem Bioenerg 1999; 48(1): 3-16. (Pubitemid 29150357)
17. Tarek M. Membrane electroporation: a molecular dynamics simulation. Biophys J 2005; 88(6): 4045-4053. (Pubitemid 40991116)
18. Kotulska M, Kubica K, Koronkiewicz S, Kalinowski S. Modeling the induction of lipid membrane electropermeabilization. Bioelectrochemistry 2006; 70(1): 83-90.
19. Vaughan EE, Dean DA. Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol Ther 2005; 13(2): 422-428.
20. Geiger RC, Taylor W, Glucksberg MR, Dean DA. Cyclic stretchinduced reorganization of the cytoskeleton and its role in enhanced gene transfer. Gene Ther 2006; 13(8): 725-731.
21. Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261(2): 377-380.
22. Gehl J, Sorensen TH, Nielsen K, et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428(2-3): 233-240.
23. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002; 1569(1-3): 51-58.
24. Khan AS, Pope MA, Draghia-Akli R. Highly efficient constant-current electroporation increases in vivo plasmid expression. DNA Cell Biol 2005; 24(12): 810-818.
25. Zampaglione I, Arcuri M, Cappelletti M, et al. In vivo DNA gene electro-transfer: a systematic analysis of different electrical parameters. J Gene Med 2005; 7(11): 1475-1481.
26. Lucas ML, Heller R. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2001; 3: 47-53. (Pubitemid 32509804)
27. Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importance of association between permeabilisation and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353-359. (Pubitemid 30209876)
28. Zupanic A, Ribaric S, Miklavcic D. Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma 2007; 54(3): 246-250.
29. Faurie C, Golzio M, Moller P, Teissié J, Rols MP. Cell and animal imaging of electrically mediated gene transfer. DNA Cell Biol 2004; 22(12): 777-783.
30. Hojman P, Eriksen J, Gehl J. In vivo imaging of far-red fluorescent proteins after DNA electrotransfer to muscle tissue. Biol Prod Online 2009; 11(1): 253-262.
31. Gehl J. Electroporation protocols: Preclinical and clinical gene medicine. 423 ed. Electroporation for drug and gene delivery in the clinic: Doctors go electric. New Jersey: Human Press 2008; 423: pp. 351-359.
32. Bureau MF, Naimi S, Torero Ibad R, et al. Intramuscular plasmid DNA electrotransfer biodistribution and degradation. BBA - Gene Structure and Expression 2004; 1676(2): 138-148. (Pubitemid 38121464)
33. Hojman P, Gissel H, Gehl J. Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation. Gene Ther 2007; 14(12): 950-959. (Pubitemid 46865506)
34. Pliquett U. Joule heating during solid tissue electroporation. Med Biol Eng Comput 2003; 41(2): 215-219. (Pubitemid 36411149)
35. Rizzuto G, Cappelletti M, Maione D, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999; 96: 6417-6422. (Pubitemid 29256680)
36. Payen E, Bettan M, Rouyer-Fessard P, Beuzard Y, Scherman D. Improvement of mouse [beta]-thalassemia by electrotransfer of erythropoietin cDNA. Exp Hematol 2001; 29(3): 295-300.
37. Maruyama H, Sugawa M, Moriguchi Y, et al. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Hum Gene Ther 2000; 11(3): 429-437.
38. Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4(11): 14-25. (Pubitemid 44755132)
39. Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4(11): 3-13. (Pubitemid 44755131)
40. Low L, Mander A, McCann KJ, et al. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009; 20(11): 1269-1278.
41. Clausen T, Gissel H. Role of Na+,K+ pumps in restoring contractility following loss of cell membrane integrity in rat skeletal muscle. Acta Physiol Scand 2005; 183(3): 263-271. (Pubitemid 40387102)
42. Hojman P, Gissel H, Andre F, et al. Physiological effects of high and low voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther 2008; 19(11): 1249-1261.
43. Chen W. Supra-physiological membrane potential induced conformational changes in K+ channel conducting system of skeletal muscle fibers. Bioelectrochemistry 2004; 62(1): 47-56. (Pubitemid 38283504)
44. Chen W. Evidence of electroconformational changes in membrane proteins: field-induced reductions in intra membrane nonlinear charge movement currents. Bioelectrochemistry 2004; 63(1-2): 333-335. (Pubitemid 38534245)
45. Chen W, Han Y, Chen Y, Astumian D. Electric Field-Induced Functional Reductions in the K+ Channels Mainly Resulted from Supramembrane Potential-Mediated Electroconformational Changes. Biophys J 1998; 75(1): 196-206. (Pubitemid 28311808)
46. Hojman P, Zibert J, Gissel H, Eriksen J, Gehl J. Gene expression profiles in skeletal muscle after gene electrotransfer. BMC Mol Biol 2007; 8(1): 5
47. Gissel H, Clausen T. Excitation-induced Ca2+ influx and skeletal muscle cell damage. Acta Physiol Scand 2001; 171: 327-334. (Pubitemid 32823800)
48. Armstrong RB. Initial events in exercise-induced muscular injury. Med Sci Sports Exerc 1990; 22(4): 429-435.
49. Rubenstrunk A, Mahfoudi A, Scherman D. Delivery of electric pulses for DNA electrotransfer to mouse muscle does not induce the expression of stress related genes. Cell Biol Toxicol 2004; 20: 25-31. (Pubitemid 38478128)
50. Sallberg M, Frelin L, Diepolder HM, et al. Activation of T cell responses and reductions in the viral load following therapeutic vaccination using naked DNA delivered by in vivo electroporation in patients with chronic hepatitis C [Abstract]. Mol Ther 2009; 17: (1)S15
51. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008; 88(4): 1379-1406.
52. Tone CM, Cardoza DM, Carpenter RH, Draghia-Akli R. Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs. Cancer Gene Ther 2004; 11(5): 389-396. (Pubitemid 38586095)
53. Draghia-Akli R, Ellis KM, Hill LA, Malone PB, Fiorotto ML. High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J 2003; 17(3): 526-528.
54. Khan AS, Draghia-Akli R, Shypailo RJ, Ellis KI, Mersmann H, Fiorotto ML. A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs. Mol Ther 2009; 18(2): 327-333.
55. Ataka K, Maruyama H, Neichi T, Miyazaki J, Gejko F. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure. Am J Nephrol 2003; 23: 315-323. (Pubitemid 37116931)
56. Kreiss P, Bettan M, Crouzet J, Scherman D. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J Gene Med 1999; 1(4): 245-250. (Pubitemid 129631117)
57. Rizzuto G, Cappelletti M, Mennuni C, et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000; 11(13): 1891-1900.
58. Samakoglu S, Fattori E, Lamartina S, et al. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles. Blood 2001; 97(8): 2213-2220. (Pubitemid 32291465)
59. Long YC, Jaichandran S, Ho LP, Tien SL, Tan SY, Kon OL. FVIII gene delivery by muscle electroporation corrects murine hemophilia A. J Gene Med 2006; 7: 494-505.
60. Fewell JG, MacLaughlin F, Mehta V, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3(4): 574-583. (Pubitemid 32509852)
61. Lee SC, Wu CJ, Wu PY, Huang YL, Wu CW, Tao MH. Inhibition of established subcutaneous and metastatic murine tumours by intramuscular electroporation of the interleukin-12 gene. J Biomed Sci 2003; 10(1): 73-86.
62. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5(6): 668-675.
63. Li S, Zhang X, Xia X, et al. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumour growth located at a distant site. Gene Ther 2001; 8(5): 400-407. (Pubitemid 32241940)
64. Zhang GH, Tan XF, Shen D, et al. Gene expression and antitumour effect following im electroporation delivery of human interferon alpha 2 gene. Acta Pharmacol Sin 2003; 24(9): 891-896.
65. Aurisicchio L, Ceccacci A, La Monica N, Palombo F, Traboni C. Tamarin alpha-interferon is active in mouse liver upon intramuscular gene delivery. J Gene Med 2001; 3(4): 394-402. (Pubitemid 33691779)
66. Martel-Renoir D, Trochon-Joseph V, Galaup A, et al. Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumour growth, and antimetastatic effect. Mol Ther 2003; 8(3): 425-433. (Pubitemid 37161464)
67. Trochon-Joseph V, Martel-Renoir D, Mir LM, et al. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res 2004; 64(6): 2062-2069. (Pubitemid 38339454)
68. Trollet C, Bloquel C, Scherman D, Bigey P. Electrotransfer into skeletal muscle for protein expression. Curr Gene Ther 2006; 6(5): 561-578. (Pubitemid 44524460)
69. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation- enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006; 6(2): 243-273.
70. Murakami T, Nishi T, Kimura E, et al. Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation. Muscle Nerve 2003; 27(2): 237-241. (Pubitemid 36169336)
71. Vilquin JT, Kennel PF, Paturneau-Jouas M, et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther 2001; 8: 1097-1107. (Pubitemid 32962707)
72. Gollins H, McMahon J, Wells KE, Wells DJ. High-efficiency plasmid gene transfer into dystrophic muscle. Gene Ther 2003; 10: 504-512. (Pubitemid 36395267)
73. Wells KE, Fletcher S, Mann CJ, Wilton SD, Wells DJ. Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. FEBS Lett 2003; 552(2-3): 145-149.
74. Takahashi T, Ishida K, Itoh K, et al. IGF-I gene transfer by electroporation promotes regeneration in a muscle injury model. Genesis 2003; 10: 612-620. (Pubitemid 36553606)
75. Rabinovsky ED, Draghia-Akli R. Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Mol Ther 2004; 9(1): 46-55.
76. Schertzer JD, Plant DR, Lynch GS. Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol Ther 2006; 13(4): 795-803.
77. Sacco A, Doyonnas R, LaBarge MA, Hammer MM, Kraft P, Blau HM. IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. J Cell Biol 2005; 171(3): 483-492. (Pubitemid 41586937)
78. Schakman O, Gilson H, de Coninck V, et al. Insulin-like growth factor-i gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology 2005; 146(4): 1789-1797. (Pubitemid 40396888)
79. Alzghoul MB, Gerrard D, Watkins BA, Hannon K. Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 2003; 18(1): 221-223.
80. Ekmark M, Gronevik E, Schjerling P, Gundersen K. Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibers after somatic DNA transfer. J Physiol (Lond) 2003; 548(1): 259-269. (Pubitemid 36410813)
81. Kramer HF, Witczak CA, Taylor EB, Fujii N, Hirshman MF, Goodyear LJ. AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J Biol Chem 2006; 281(42): 31478-31485. (Pubitemid 46041412)
82. Cleasby ME, Davey JR, Reinten TA, et al. Acute bidirectional manipulation of muscle glucose uptake by in vivo electrotransfer of constructs targeting glucose transporter genes. Diabetes 2005; 54(9): 2702-2711.
83. Bruce CR, Brolin C, Turner N, et al. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am J Physiol Endocrinol Metab 2007; 292: E1231-E123
84. Roorda BD, Hesselink MKC, Schaart G, et al. DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content. J Lipid Res 2005; 46(2): 230-236.
85. Ban A, Yamanouchi K, Matsuwaki T, Nishihara M. In vivo Gene transfer of PPARγ is insufficient to induce adipogenesis in skeletal muscle. J Vet Med Sci 2008; 70(8): 761-767.
86. Matthews VB, Astrom MB, Chan MHS, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 2009; 52(7): 1409-1418.
87. Shi H, Scheffler JM, Pleitner JM, et al. Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. FASEB J 2008; 22(8): 2990-3000.
88. Ekmark M, Gronevik E, Schjerling P, Gundersen K. Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibers after somatic DNA transfer. J Physiol Online 2003; 548(1): 259-269. (Pubitemid 36410813)
89. Nielsen AR, Hojman P, Erikstrup C, et al. Association between IL-15 and obesity: IL-15 as a potential regulator of fat mass. J Clin Endocrinol Metab 2008; 93(11): 4486-4493. (Pubitemid 352789551)
90. Magee TR, Artaza JN, Ferrini M, et al. Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J Gene Med 2006; 8(9): 1171-1181. (Pubitemid 44480408)